Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|February 7, 2012
[A retrospective endoscopic case of adenoid cystic carcinoma of the esophagus]Ryo Miyata, Tooru Niihara, Shunji Shimaoka, et al.Interactive Cardiovascular and Thoracic Surgery|October 15, 2021
Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors as a first-line treatment for postoperative recurrent and EGFR-mutated non-small-cell lung cancerTetsuji Moriya, Masatsugu Hamaji, Akihiko Yoshizawa, et al.Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|December 6, 2011
[A case of eosinophilic gastroenteritis with ring-like discoloration in the lower end of the esophagus]Ryo Miyata, Hiromitsu Torimaru, Shunji Shimaoka, et al.Cancer Medicine|January 11, 2018
The synergistic role of ATP-dependent drug efflux pump and focal adhesion signaling pathways in vinorelbine resistance in lung cancerTakao Nakanishi, Toshi Menju, Shigeto Nishikawa, et al.Surgery Today|November 16, 2018
Survival outcomes after minimally invasive thymectomy for early-stage thymic carcinomaRyo Miyata, Masatsugu Hamaji, Mitsugu Omasa, et al.Surgery Today|June 15, 2020
Are volume-dependent parameters in positron emission tomography predictive of postoperative recurrence after resection in patients with thymic carcinoma?Masatsugu Hamaji, Sho Koyasu, Mitsugu Omasa, et al.Interactive Cardiovascular and Thoracic Surgery|June 21, 2021
Lymph node dissection in thymic carcinomas and neuroendocrine carcinomasMasatsugu Hamaji, Mitsugu Omasa, Takao Nakanishi, et al.Surgery Today|January 15, 2025
Clinical significance of the preoperative prognostic nutritional index in patients with resectable non-small cell lung cancer: a multicenter studyMamoru Takahashi, Akihiro Aoyama, Masatsugu Hamaji, et al.Surgery Today|August 11, 2020
The treatment and survival of patients with postoperative recurrent thymic carcinoma and neuroendocrine carcinoma: a multicenter retrospective studyRyo Miyata, Masatsugu Hamaji, Mitsugu Omasa, et al.Surgery Today|July 2, 2022
Postoperative tegafur-uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysisRyo Miyata, Masatsugu Hamaji, Akiyoshi Nakakura, et al.Pageof 10